ArticleThe Lancet regional health. Western Pacific2026
Trends and transition dynamics of heated tobacco product use in Japan, 2015-2025: a repeated cross-sectional and longitudinal study.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heated tobacco products (HTPs) diffused rapidly in Japan, but transition dynamics remain unclear. We examined trends in HTP use and routes underlying its growth. Methods: Using data from the Japan Society and New Tobacco Internet Survey, 2015-2025, we estimated weighted prevalence of HTP use (N = 161,583). Sex- and age-standardised prevalence was used to estimate segmented trends with a 2018 knot. Among respondents observed in consecutive years (93,540 pairs), we fitted a multinomial transition model across five states (Never, Non-current, Cigarette-only, HTP-only, and Dual use) and decomposed changes in standardised HTP prevalence into four categories: uptake from Never/Non-current states, switching from Cigarette-only to HTP, switching back to Cigarette-only, and exit to Non-current use. Findings: Weighted HTP prevalence increased from 0.1% to 14.9% during 2015-2025. Standardised prevalence rose sharply through 2018 (3.33 percentage points/year) and more gradually thereafter (0.92 percentage points/year). Transition probabilities showed post-2018 persistence of HTP-only/Dual use (67.9% and 57.0%, respectively). In the longitudinal decomposition, mean annual entry into HTP use increased from 2.16 percentage points before 2018 to 3.48 after 2018, while mean annual exit changed from -0.39 to -2.30. After 2018, entry from Non-current states increased markedly, whereas contributions from Never states were smaller and switching from Cigarette-only to HTP remained substantial. Interpretation: HTP use in Japan shifted around 2018 from rapid expansion to slower but sustained growth. Within the transition-eligible sample, later growth reflected multiple dynamics-including continued cigarette-to-HTP switching, persistence within HTP-using states, and increasing uptake from Non-current states-rather than cigarette substitution alone. Funding: Japan Society for the Promotion of Science KAKENHI (25H01079).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.